Opportunities and Gaps in the Global Onco-Immunotherapy Market by Epidemiology, By Variation in Therapy, by Class of Drugs (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators and Interferons Alpha),  By Diagnosis (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck) , By End-User Location (Hospital, Clinics and Home Based) and by Region (North America, Western Europe, Asia-Pacific, Rest of the World)